These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22998238)

  • 1. Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV.
    Weckmann M; Moir LM; Heckman CA; Black JL; Oliver BG; Burgess JK
    J Cell Mol Med; 2012 Dec; 16(12):3062-73. PubMed ID: 22998238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
    Koskimaki JE; Lee E; Chen W; Rivera CG; Rosca EV; Pandey NB; Popel AS
    Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
    Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
    Lee E; Rosca EV; Pandey NB; Popel AS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1812-21. PubMed ID: 21920451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells.
    Tai HC; Lee TH; Tang CH; Chen LP; Chen WC; Lee MS; Chen PC; Lin CY; Chi CW; Chen YJ; Lai CT; Chen SS; Liao KW; Lee CH; Wang SW
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30959907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor.
    Nyberg P; Xie L; Sugimoto H; Colorado P; Sund M; Holthaus K; Sudhakar A; Salo T; Kalluri R
    Exp Cell Res; 2008 Nov; 314(18):3292-305. PubMed ID: 18775695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA; Luo JX; Zhang TY; Wang FY; Li RF
    Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
    Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Ngiwsara L; Svasti J; Koizumi K
    Vasc Med; 2018 Jun; 23(3):201-211. PubMed ID: 29629844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
    Ma C; Yin H; Zhong J; Zhang Y; Luo C; Che D; Fang Z; Li L; Qin S; Liang J; Qi W; Yang Z; Zhou T; Ma J; Yang X; Gao G
    Int J Oncol; 2017 Jun; 50(6):2000-2010. PubMed ID: 28440474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
    Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
    Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
    Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model.
    Yoo KH; Park JH; Lee DY; Hwang-Bo J; Baek NI; Chung IS
    Phytother Res; 2015 May; 29(5):714-23. PubMed ID: 25644809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis.
    Esa R; Steinberg E; Dror D; Schwob O; Khajavi M; Maoz M; Kinarty Y; Inbal A; Zick A; Benny O
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
    Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
    BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.